Background The stability of parathyroid hormone (PTH) in blood ex vivo is a significant practical problem for laboratories and clinicians. Several studies have suggested that PTH is more stable in blood collected into a potassium edetate (EDTA) preservative.
Introduction
Measurement of circulating parathyroid hormone (PTH) is used in the di¡erential diagnosis of disorders of calcium metabolism. For laboratories supporting renal dialysis units, however, the majority of the workload is derived from patients with end-stage renal failure, where it is used as an indicator of bone turnover. The instability of PTH has always been an issue of practical concern for laboratories and clinicians. In particular, in relation to its use in renal failure, samples may need to be collected at inconvenient times (e.g. twilight dialysis clinics) or in settings remote from the main laboratory (e.g. satellite dialysis units). Recently, several reports have suggested that the stability of PTH is improved if plasma collected with a potassium edetate (EDTA) preservative is used, and several manufacturers now recommend this as the sample of choice for PTH measurement.We wanted to con¢rm that this was applicable to renal dialysis patients using our assay.
Methods
Blood from 13 patients was collected immediately before haemodialysis into Vacutainer TM tubes (Becton-Dickinson Ltd) which contained either no additives (plain), a plastic plug and a clot enhancer (serum separator tubes, SSTs) or potassium EDTA. The tubes were ¢lled with the recommended volume of blood. Aliquots of serum and plasma were frozen (7208C) rapidly after centrifugation (zero time). The remaining serum/plasma was removed from the cells and left at room temperature, with further aliquots being frozen at 2, 4, 8, 12, 24 and 48 h. These time points were chosen pragmatically to re£ect typical and maximal times taken for processing of samples received from hospital outreach clinics or primary care. Samples were analysed in duplicate using an immunochemiluminesc ence assay (Nichols Institute Diagnostics Ltd, Middlesex, UK; reference range 10^65 ng/L). All of the samples from each individual patient were analysed in a single batch to minimize the e¡ects of between-batch imprecision. All patients gave informed consent and the study had the approval of the East Kent Local Research Ethics Committee.
Short Report
concentration in SST serum did not di¡er (Pˆ0¢6) from that in plain serum; median PTH in EDTA plasma was 4% lower (range717% to +3%, Pˆ0¢006) than in plain serum (see Table 1 ). Time delay before freezing had a signi¢cant e¡ect (Friedman's ANOVA) on stability in plain and SST serum (P50¢05), but not in EDTA plasma (P40¢05). PTH concentration decreased signi¢cantly after 2 h in plain, and after 4 h in SST, serum. After 48 h, median PTH concentration in plain serum decreased by 47% (range 21^66%) and in SST serum by 26% (range 15^55%).
Discussion
Using an immunochemiluminescence assay, we have observed signi¢cant improvements in the stability of PTH in blood taken from patients with end-stage renal failure using EDTA plasma instead of serum. Our results are broadly in keeping with those of other investigators, using a variety of analytical systems. Using the Nichols Allegro assay, Newman and Ashby showed that PTH concentrations decreased by 14% over 18 h in serum and by 32% in whole blood. 1 Levin and Nisbet found that PTH decreased by 47% over 72 h, but did not decrease in EDTA or heparinized plasma. 2 In keeping with our data, Levin and Nisbet 2 also found that PTH concentrations at zero time were 6% lower in EDTA plasma than in serum. Ratcli¡e et al. 3 observed decreases of 17% in serum PTH concentration over 24 h and 32% in whole blood samples using an Incstar assay. Russell and Henley, 4 using Ciba-Corning Magiclite, found PTH to be stable in both whole blood SST and in serum for up to 6 h at room temperature. However, samples stored at room temperature for 24^30 h showed signi¢cant decreases in measured PTH, with whole blood and serum concentrations falling by 25% and 30%, respectively. Walker and Seth 5 also studied renal dialysis patients, using the DPC Immulite assay, and observed a 10% decrease in PTH after 12 h storage as whole blood; concentrations in EDTA plasma remained stable. Our study con¢rms and extends their ¢ndings, with no signi¢cant decrease in plasma PTH concentration being observed during 48 h of storage at room temperature.
In our study, the serum and plasma samples were stored after separation from the cells. Other studies have compared storage between whole blood and serum; two of these 1, 3 found that serum was more stable than whole blood (14^17% decrease over 18^24 h compared with 32%). Russell and Henley 4 found whole blood to be slightly more stable than serum (25% decrease over 24^30 h compared with 30%). Due to restraints on the volume of blood we could reasonably collect from patients, we were unable to study this aspect.
Glendenning et al., 6 using the Immulite 2000, found that, at baseline, PTH in serum from SST was 35% lower than in EDTA plasma. After 3 days of storage, measured PTH concentration in EDTA plasma had not decreased, but had declined by more than 40% in serum. Omar et al., 7 using the Immulite 2000, also observed improved stability in EDTA plasma. However, in their study, PTH concentrations in fresh EDTA plasma were 20% higher than in fresh serum. They concluded that use of EDTA plasma would necessitate re-evaluation of the reference range and that this outweighed the advantages of improved stability.
Di¡erences between these studies may re£ect di¡ering assay principles and study populations; for example, Omar et al. used non-uraemic subjects with predominantly normal PTH concentrations. The two studies using Immulite 2000 6, 7 both showed PTH to be higher in EDTA plasma than serum at baseline, whereas our study and that of Levin and Nisbet 2 showed PTH to be slightly lower. There may have also been subtle di¡erences in sample handling and preparation. In our study, although plasma PTH concentrations at baseline were slightly lower than those in serum, in practice the di¡erences were marginal, especially given the rapid degradation of PTH in plain and SSTs and the di¤culties of ensuring rapid frozen storage in a routine laboratory setting. Additionally, the interpretation of PTH concentrations is based oǹ appropriateness' in relation to the prevailing calcium concentration or, in the setting of end-stage renal failure, on fairly crude guidance 8 that PTH concentrations should be less than four times the upper limit of normal.
Conclusion
We conclude that the use of EDTA plasma for PTH measurement o¡ers signi¢cant practical advantages, especially when rapid frozen separation of blood is hard to achieve.
